Search

everythinglearnresearchcommunity

for

Search:↓

Talazoparib is more effective than standard chemotherapy for advanced breast cancer with BRCA mutations.

Betamethasone valerate foam is more effective and safe for treating mild-to-moderate alopecia areata than betamethasone dipropionate lotion.

Lenalidomide effectively and safely treats skin symptoms in pediatric lupus, reducing the need for prednisone.

Deuruxolitinib is FDA-approved for treating severe alopecia areata.

Ponatinib can cause a rare skin reaction that resolves with topical treatment and temporary drug discontinuation.

Advanced therapy medicinal products show promise for vitiligo treatment with fewer side effects, but affordability is a challenge.

Alisertib was found to be an effective and tolerable treatment for children with recurrent brain tumors.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

A 25-year-old man with multiple skin tumors was successfully treated with acitretin and methotrexate.

NB-UVB phototherapy is an effective and safe treatment for vitiligo, especially on hands and feet, and can be improved with tacrolimus.

Continuous baricitinib is needed to keep hair regrowth in severe alopecia areata.

Baricitinib helped treat a man's beard hair loss when steroids didn't work.

Methotrexate is a key, cost-effective drug for skin conditions, but requires careful monitoring for side effects.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.

The treatment was ineffective in humans.

Combining pentoxifylline with corticosteroids improves alopecia areata treatment.

Targeted therapy with Ustekinumab significantly improved a skin condition called ILVEN, which is caused by mutations in the CARD14 gene.

Baricitinib was effective in treating both early and late onset alopecia areata.

Methotrexate is effective and well-tolerated in children for certain skin conditions but requires careful monitoring.

Doxil is an effective, modified chemotherapy drug with a unique toxicity profile and shows promise in treating certain cancers.

Biological therapy boosts the immune system to effectively fight melanoma.

Combining dutasteride mesotherapy with oral minoxidil is more effective for hair loss than using oral minoxidil alone.

A cancer drug caused unusual hair growth on a 100-year-old man's scalp and eyelashes.

The study found two new mutations in a Chinese patient with severe biotinidase deficiency.

Tofacitinib was more effective than methotrexate for treating alopecia areata.

Early intervention and tailored management are crucial for skin side effects in cancer treatments.

Actemra is approved for a specific artery condition, HIV treatment adherence has improved, women may pay more for a hair loss product, and incorrect dosing of blood thinners can be risky.